97.6%
GSK3685032ZebularineAZAazacytidinepediatric brain tumorsmedulloblastomahematologic malignanciespediatric gliomaChimeric antigen receptor (CAR) T-cell therapyU87
…ase inhibition (DNMTi) using azacytidine (AZA), zebularine, and GSK3685032, added during GMP-compatible manufacturing of B7-H3 -targeting …